Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,941 to 1,960 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nature as a treasure trove of potential anti-SARS-CoV drug leads: a structural/mechanistic rationale. | RSC Adv | 2020 | 35685913 | PubTator, text mining | PubMed |
| Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease. | RSC Adv | 2020 | 35520818 | PubTator, text mining | PubMed |
| Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses. | RSC Adv | 2020 | 35519104 | PubTator, text mining | PubMed |
| Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2. | Mol Biomed | 2020 | 34765992 | PubTator, text mining | PubMed |
| Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion. | Oxf Open Immunol | 2020 | 34192267 | PubTator, text mining | PubMed |
| Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics. | RSC Med Chem | 2020 | 34041486 | PubTator, text mining | PubMed |
| A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. | Front Pharmacol | 2020 | 33815095 | PubTator, text mining | PubMed |
| Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review. | Iran J Pharm Res | 2020 | 33680028 | PubTator, text mining | PubMed |
| Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | Front Cell Dev Biol | 2020 | 33644029 | PubTator, text mining | PubMed |
| Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island. | Front Microbiol | 2020 | 33643227 | PubTator, text mining | PubMed |
| Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection. | Front Public Health | 2020 | 33634060 | PubTator, text mining | PubMed |
| Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects. | Front Immunol | 2020 | 33613542 | PubTator, text mining | PubMed |
| Genomic Analysis of an Indian G8P[1] Caprine Rotavirus-A Strain Revealing Artiodactyl and DS-1-Like Human Multispecies Reassortment. | Front Vet Sci | 2020 | 33585597 | PubTator, text mining | PubMed |
| SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways. | Front Mol Biosci | 2020 | 33585554 | PubTator, text mining | PubMed |
| 2020 update on human coronaviruses: One health, one world. | Med Nov Technol Devices | 2020 | 33521622 | PubTator, text mining | PubMed |
| SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress. | Front Physiol | 2020 | 33519510 | PubTator, text mining | PubMed |
| Whole Genome Analysis of African G12P[6] and G12P[8] Rotaviruses Provides Evidence of Porcine-Human Reassortment at NSP2, NSP3, and NSP4. | Front Microbiol | 2020 | 33510725 | PubTator, text mining | PubMed |
| Exploring rotavirus proteome to identify potential B- and T-cell epitope using computational immunoinformatics. | Heliyon | 2020 | 33426322 | PubTator, text mining | PubMed |
| SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production. | Viruses | 2020 | 33396605 | PubTator, text mining | PubMed |
| Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. | Int J Mol Sci | 2020 | 33396557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=98